AI systems will change from being “copilots” that require human steering to being reliable executors of complex tasks. Right now, AI is impressive but.
TransCelerate BioPharma has released its 2025 annual report, titled The Power of Forward, outlining a year defined by continued digital adoption, regulatory collaboration, and expansion of pragmatic ...
In the first instalment of LCGC International's interview series exploring how artificial intelligence (AI)/machine learning ...
Lung cancer remains the leading cause of cancer-related mortality worldwide. Early detection of pulmonary nodules is crucial for timely diagnosis and ...
First ever successful demonstration of superiority in an FDA-aligned wet AMD trial comparing a novel investigative agent to an approved anti-VEGF ...
AXPAXLI (TM) (also known as OTX-TKI) is an investigational, bioresorbable, intravitreal hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase inhibitor with anti-angiogenic ...
From the moment authorities confirmed she was missing the case quickly moved beyond a routine investigation. Her age the unusual circumstances ...
Company collaborating with third parties using "proprietary artificial intelligence and machine learning technologies to ...
Singular Genomics, a company delivering high-throughput spatial technologies to advance precision medicine, today announced ...
The UN points out that the world population is expected to grow from the current 8 billion people to around 10 billion by ...
Good morning, everyone, and thank you for joining us today. Earlier this morning, we issued a press release outlining the positive topline results from our SOL-1 Phase III clinical trial of AXPAXLI, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results